Method of attacking target cells
OwnerRobert E. Sandstrominventor
Life of this patent
Estimating the term…
Abstract
A method of killing cells of a targeted cell type in a patient body that utilizes nanoparticles having a first portion, which when exposed to a target portion of a targeted cell type, binds to the target portion and a second portion, joined to the first portion, and comprised of a low resistivity material. The nanoparticles are introduced into a contact area where they contact cells of the targeted cell type. Contemporaneously, the contact area is exposed to a varying magnetic field of insufficient strength to increase the temperature of any part of the patient body by more than ten degrees Celsius, but which creates a current at the nanoparticles sufficient to disrupt function of the targeted cell type.
Claims22
A method of killing cells of a targeted cell type in a patient, comprising:
- (a) providing nanoparticles having:
- (i) a first portion, of a type taken from a group consisting of:
- an antibody and an aptamer, which when exposed to a target portion of a targeted cell type, binds with specificity to said target portion;
- and
- (ii) a second portion, joined to said first portion, and comprised of a low resistivity material;
- (b) introducing said nanoparticles into a contact area where they can contact said cells of said targeted cell type;
- (c) exposing said contact area to a varying magnetic field of insufficient strength to damage said patient, but which creates a current at said nanoparticles sufficient to disrupt functioning of said targeted cell type.
Dependencies are inferred from the claim text.